News in the Life Sciences Industry

SHANGHAI and LEVERKUSEN, Germany, Jan. 15, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, and Bayer jointly announced an acquisition... Read more ››

LOVELAND, Colo., Jan. 14, 2020 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty products, announced today that the Company has entered into an agreement (the "Agreement") to acquire 100% of the capital... Read more ››

SAN DIEGO, Jan. 14, 2020 /PRNewswire/ -- My Green Lab is pleased to announce a collaboration with AstraZeneca to implement a global-scale green labs program across their research sites as part of their commitment to sustainability, including protecting the environment.

SEOUL, South Korea, Jan. 14, 2020 /PRNewswire/ -- Genome & Company (KONEX: 314130) is pleased to announce that it has entered into a clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer Inc. to evaluate the safety, tolerability, biological and clinical... Read more ››

BOSTON, Jan. 13, 2020 /PRNewswire/ -- binx health today announced the launch of its pre-order program for the world's first FDA-cleared, rapid molecular point-of-care instrument, which provides diagnosis in about 30 minutes to enable single visit test and treatment for chlamydia (CT) and gonorrhea... Read more ››

ABBOTT PARK, Ill., Jan. 13, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved a first-of-its-kind clinical trial that will compare the effectiveness of Abbott's minimally invasive MitraClip(TM) device - which has now treated... Read more ››

FRANKFURT, Germany, Jan. 13, 2020 /PRNewswire/ -- The Journal of Electrocardiology has published a study showing unparalleled accuracy in non-invasive coronary artery disease (CAD) detection using Cardisio's new low-cost method which involves no radiation exposure.

SINGAPORE, Jan. 12, 2020 /PRNewswire/ -- Mundipharma today announced a partnership with Samsung Bioepis to commercialize Samsung Bioepis' first-wave biosimilar candidates in Taiwan and Hong Kong.

INDIANAPOLIS and BERLIN and BAD NAUHEIM, Germany, Jan. 9, 2020 /PRNewswire/ -- FAST BioMedical announced the completion of the EMPAKT-CHF clinical trial at Charité - Universitätsmedizin Berlin and Kerckhoff Klinik in Bad Nauheim. The trial evaluated the impact of FAST BioMedical's Blood... Read more ››